Sign in to view content

Reduction in the Frequency of Diabetic Macular Edema (DME) Therapies Post-0.2 ug/Day Fluocinolone Acetonide (FAc) Implant Treatment Results

Sam E. Mansour, MD, MSc,FACS, FRCS(C)

Video
Published 2018

Related

To Treat or Not to Treat: Are We Sacrificing Treatment Outcomes by Allowing Diabetic Retinopathy (DR) to Enter the Proliferative Stage?
Michael J. Elman, MD
Annual Meeting Talks
2018
Confirmatory 1-Year Study Results of an Injectable Fluocinolone Acetonide Intravitreal Insert to Treat Noninfectious Posterior Segment Uveitis
Glenn J. Jaffe, MD
Annual Meeting Talks
2018
Ultra-widefield OCTA for Evaluation of Vascular Perfusion
Kasra Rezaei, M.D.
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more